Employment Outlook Positive During June Quarter Of 2022-23: Report
Growth momentum continued in the March quarter of 2021-22 and even during the ongoing first quarter of the current fiscal, a FICCI survey noted
Stay updated with breaking news from Pharma Sector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Growth momentum continued in the March quarter of 2021-22 and even during the ongoing first quarter of the current fiscal, a FICCI survey noted
Foreign Direct Investment (FDI) equity inflows into India contracted marginally by 1 per cent to $58.77 billion during 2021-22
Indian manufacturers will soon have an opportunity to work with WHO’s COVID-19 Technology Access Pool and the Medicines Patent Pool for developing innovative therapeutics, vaccines and diagnostics against coronavirus.
Indian pharma companies enabled by their price competitiveness and good quality, have made global mark, with 60 per cent of the world’s vaccines and 20% of generic medicines coming from India.
Indian pharma exports witnessed a growth of 103 per cent since 2013-14